局部前列腺癌的傳統治療方案包括前列腺切除術、放射治療和主動監測。然而，前列腺切除術和放射治療具有一定程度的發病率，包括尿失禁、勃起功能障礙和附近結構受傷的風險。主動監測會對患者帶來疾病進展和心理困擾的風險。
適應症：Prostate Cancer
收案條件
納入條件
- Men aged between 40 - 85 years
- Visible index lesion(s) on MRI
- Found to have localized prostate cancer after MRI-USG fusion targeted biopsy or USG-guided template biopsy: Clinical tumour stage \<=T2, or Gleason score \<=7, or PSA \<= 20 ng/ml
排除條件
- Patients unfit for contrast MRI exam
- Patients with active urinary tract infection
- Patients with bladder pathology including bladder stone and bladder cancer
- Patients with urethral stricture
- Patients with neurogenic bladder and/or sphincter abnormalities
- Patients who fail to give informed consent
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。